Intervention

leukapheresis

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions10

Lead sponsors shown3

Clinical trials

4 shown

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa PatientsNCT06469710 · 2024-06-25

Vaccine Therapy in Treating Patients With Stage IV Breast CancerNCT00791037 · 2008-10-01

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast CancerNCT00343109 · 2004-03-01

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected PatientsNCT00333892 · 2003-08-01

Common conditions

HER2-positive Breast Cancer2 Male Breast Cancer2 Stage IV Breast Cancer2 Circulating Tumor Cell1 Human Immunodeficiency Virus1 Leukapheresis1 Prostate Cancer1 Recurrent Breast Cancer1 Stage IIIB Breast Cancer1 Stage IIIC Breast Cancer1

Leading sponsors

University of Washington2 Canadian Immunodeficiency Research Collaborative1 RenJi Hospital1

Trial status mix

COMPLETED3

RECRUITING1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.